Viewing Study NCT02938793


Ignite Creation Date: 2025-12-25 @ 1:26 AM
Ignite Modification Date: 2026-02-23 @ 8:09 PM
Study NCT ID: NCT02938793
Status: TERMINATED
Last Update Posted: 2025-09-23
First Post: 2016-10-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Durvalumab in Combination With Tremelimumab in Subjects With Advanced Rare Solid Tumors
Sponsor: Prisma Health-Upstate
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module